Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Changmao Biochemical Engineering Co. Ltd. Class H ( (HK:0954) ) has issued an announcement.
Changmao Biochemical Engineering Co. Ltd. has announced its upcoming Annual General Meeting (AGM) scheduled for May 28, 2025, in Hong Kong. Key agenda items include the approval of the 2024 financial statements, the resignation and election of directors and supervisors, and the re-appointment of PricewaterhouseCoopers as the company’s auditor. Additionally, a special resolution will be considered to grant the board a mandate to issue new shares, which could impact the company’s capital structure and shareholder value.
More about Changmao Biochemical Engineering Co. Ltd. Class H
Changmao Biochemical Engineering Co. Ltd. is a joint stock limited company incorporated in the People’s Republic of China, operating in the biochemical engineering industry. The company is listed on the Hong Kong Stock Exchange and focuses on the production and development of biochemical products.
YTD Price Performance: -32.00%
Technical Sentiment Signal: Buy
Current Market Cap: €18.41M
For a thorough assessment of 0954 stock, go to TipRanks’ Stock Analysis page.